Wesfarmers reported EBIT growth of 8% in 1H26. There was solid growth in its retail business and an outsized earnings improvement in lithium and associate income. The shape of the result raises debate about the likely operating leverage in Bunnings and Kmart, which we expect to be modest, especially as depreciation expenses normalise. We are also likely to see slowing sales trends on a 12-month horizon given weaker household income growth and fading price inflation. Wesfarmers will have solid EPS growth of 7% over FY26e and FY27e helped by higher lithium prices.

Wesfarmers reported EBIT growth of 8% in 1H26. There was solid growth in its retail business and an outsized earnings improvement in lithium and associate income. The shape of the result raises debate about the likely operating leverage in Bunnings and Kmart, which we expect to be modest, especially as depreciation expenses normalise. We are also likely to see slowing sales trends on a 12-month horizon given weaker household income growth and fading price inflation.

Wesfarmers reported FY25 EBIT of $4,186 million, growth of 5%. The result was helped by higher equity profits and lower depreciation, so EBITDA growth of 3% is a better proxy of the performance in the year. Bunnings, Kmart and Officeworks outlook for earnings growth is modest with limited margin expansion likely as depreciation rises and cost savings are largely offset by cost inflation. We expect WesCEF EBIT to fall 15% in FY26e given larger losses for lithium and lower ammonia prices.

Woolworths has made a bid for API, trumping Wesfarmers takeover offer. This battle has just begun. Both companies have the balance sheet. Both see improvements in Priceline’s sales and earnings. Wesfarmers is likely to place a greater value on both the Priceline loyalty members and the platform API may create for a Health division in our view.